Ameriprise’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.4M Buy
101,674
+2,848
+3% +$72.7K ﹤0.01% 2865
2025
Q4
$2.87M Sell
98,826
-359
-0.4% -$9.19K ﹤0.01% 2804
2025
Q3
$1.87M Buy
99,185
+141
+0.1% +$2.22K ﹤0.01% 3036
2025
Q2
$1.39M Sell
99,044
-14,335
-13% -$201K ﹤0.01% 3135
2025
Q1
$1.77M Sell
113,379
-26,550
-19% -$374K ﹤0.01% 2957
2024
Q4
$1.95M Buy
139,929
+50,662
+57% +$555K ﹤0.01% 2942
2024
Q3
$830K Buy
89,267
+11,861
+15% +$117K ﹤0.01% 3291
2024
Q2
$720K Sell
77,406
-16,534
-18% -$150K ﹤0.01% 3302
2024
Q1
$931K Sell
93,940
-985,640
-91% -$7.36M ﹤0.01% 3192
2023
Q4
$3.49M Buy
+1,079,580
New +$2.93M ﹤0.01% 2589
2023
Q3
Sell
-337,052
Closed -$3.21M 3888
2023
Q2
$3.21M Sell
337,052
-517,682
-61% -$5.75M ﹤0.01% 2632
2023
Q1
$9.4M Buy
854,734
+41,112
+5% +$595K ﹤0.01% 1822
2022
Q4
$12M Buy
813,622
+158,944
+24% +$2.78M ﹤0.01% 1587
2022
Q3
$12.5M Buy
654,678
+110,490
+20% +$2.5M ﹤0.01% 1490
2022
Q2
$11.6M Buy
544,188
+113,926
+26% +$2.34M ﹤0.01% 1620
2022
Q1
$8.29M Buy
430,262
+213,859
+99% +$3.62M ﹤0.01% 2058
2021
Q4
$4.49M Sell
216,403
-145,632
-40% -$2.9M ﹤0.01% 2547
2021
Q3
$8.65M Buy
362,035
+7,155
+2% +$163K ﹤0.01% 1970
2021
Q2
$9.69M Buy
354,880
+37,677
+12% +$1.06M ﹤0.01% 1963
2021
Q1
$9.18M Buy
317,203
+202,086
+176% +$6.31M ﹤0.01% 1953
2020
Q4
$3.24M Sell
115,117
-169,329
-60% -$4.15M ﹤0.01% 2547
2020
Q3
$8.33M Buy
284,446
+6,427
+2% +$172K ﹤0.01% 1681
2020
Q2
$8.41M Buy
278,019
+23,580
+9% +$681K ﹤0.01% 1658
2020
Q1
$7.58M Buy
+254,439
New +$6.84M ﹤0.01% 1594

Other funds holding ARQT